Do AutoML-Based QSAR Models Fulfill OECD Principles for Regulatory Assessment? A 5-HT(1A) Receptor Case

The drug discovery and development process requires a lot of time, financial, and workforce resources. Any reduction in these burdens might benefit all stakeholders in the healthcare domain, including patients, government, and companies. One of the critical stages in drug discovery is a selection of...

Descripción completa

Detalles Bibliográficos
Autores principales: Czub, Natalia, Pacławski, Adam, Szlęk, Jakub, Mendyk, Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319483/
https://www.ncbi.nlm.nih.gov/pubmed/35890310
http://dx.doi.org/10.3390/pharmaceutics14071415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319483/
https://www.ncbi.nlm.nih.gov/pubmed/35890310
http://dx.doi.org/10.3390/pharmaceutics14071415

Ejemplares similares